Clinical efficacy and safety of topical treatment of atopic dermatitis
https://doi.org/10.21518/2079-701X-2013-1-1-66-71
Abstract
The article tells about results of clinical use of national non-hormonal topical treatment - Tsinokap cream. The active ingredient is zinc pyrithione 0.2% with anti-inflammatory, antibacterial and antifungal effect. A group of children with atopic dermatitis aged 1 to 16 years applied Tsinokap cream for 4 weeks. Clinical observations and analysis of dynamics of standardized SCORAD index during the treatment proved high efficiency of the therapy and its safety. Use of Tsinokap by patients with atopic dermatitis was associated with an increase in the quality of life in all age groups.
About the Authors
N. V. Kungurov
ФГБУ «Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии» Минздрава России
Russian Federation
M. M. Kokhan
ФГБУ «Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии» Минздрава России
Russian Federation
Y. V. Koenigsfest
ФГБУ «Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии» Минздрава России
Russian Federation
Views:
568